Recently, a collaborative study involving our centre has shown that upregulation of somatostatin receptor 2 (SSTR2) in NPC is also mediated by LMP1, and this may potentially be amenable to therapeutic blockade (179). This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.